|
1
|
Chen X, Liu H, Tang Z, Yu Y and Zang G:
The modification of Tapasin enhances cytotoxic T lymphocyte
activity of intracellularly delivered CTL epitopes via cytoplasmic
transduction peptide. Acta Biochim Biophys Sin (Shanghai).
45:203–212. 2013. View Article : Google Scholar
|
|
2
|
Wang FS, Fan JG, Zhang Z, Gao B and Wang
HY: The global burden of liver disease: The major impact of China.
Hepatology. 60:2099–2108. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chisari FV, Isogawa M and Wieland SF:
Pathogenesis of hepatitis B virus infection. Pathol Biol (Paris).
58:258–266. 2010. View Article : Google Scholar
|
|
4
|
Ganem D and Prince AM: Hepatitis B virus
infection-natural history and clinical consequences. N Engl J Med.
350:1118–1129. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Thimme R, Wieland S, Steiger C, Ghrayeb J,
Reimann KA, Purcell RH and Chisari FV: CD8(+) T cells mediate viral
clearance and disease pathogenesis during acute hepatitis B virus
infection. J Virol. 77:68–76. 2003. View Article : Google Scholar :
|
|
6
|
Asabe S, Chattopadhyay PK, Roederer M,
Engle RE, Purcell RH and Chisari FV: The size of the viral inoculum
contributes to the outcome of hepatitis B virus infection. J Virol.
83:9652–9662. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Phillips S, Chokshi S, Riva A, Evans A,
Williams R and Naoumov NV: CD8(+) T cell control of hepatitis B
virus replication: Direct comparison between cytolytic and
noncytolytic functions. J Immunol. 184:287–295. 2010. View Article : Google Scholar
|
|
8
|
Leonhardt RM, Abrahimi P, Mitchell SM and
Cresswell P: Three tapasin docking sites in TAP cooperate to
facilitate transporter stabilization and heterodimerization. J
Immunol. 192:2480–2494. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hulpke S, Baldauf C and Tampé R: Molecular
architecture of the MHC I peptide-loading complex: One tapasin
molecule is essential and sufficient for antigen processing. FASEB
J. 26:5071–5080. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tang YY, Tang ZH, Zhang Y, Zhuo M, Zang
GQ, Chen XH and Yu YS: The fusion protein of CTP-HBcAg18-27-Tapasin
mediates the apoptosis of CD8(+)T cells and CD8(+) T cell response
in HLA-A2 transgenic mice. Hepat Mon. 14:e161612014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen X, Tang Y, Zhang Y, Zhuo M, Tang Z,
Yu Y and Zang G: Tapasin modification on the intracellular epitope
HBcAg18-27 enhances HBV-specific CTL immune response and inhibits
hepatitis B virus replication in vivo. Lab Invest. 94:478–490.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Steinke JW, Liu L, Turner RB, Braciale TJ
and Borish L: Immune surveillance by rhinovirus-specific
circulating CD4+ and CD8+ T lymphocytes. PLoS
One. 10:e01152712015. View Article : Google Scholar
|
|
13
|
Ashraf S, Nitschke K, Warshow UM, Brooks
CR, Kim AY, Lauer GM, Hydes TJ, Cramp ME, Alexander G, Little AM,
et al: Synergism of tapasin and human leukocyte antigens in
resolving hepatitis C virus infection. Hepatology. 58:881–889.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pei J, Tang Z, Zang G and Yu Y: Blockage
of Notch1 signaling modulates the T-helper (Th)1/Th2 cell balance
in chronic hepatitis B patients. Hepatol Res. 40:799–805. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Crawford TQ, Ndhlovu LC, Tan A, Carvidi A,
Hecht FM, Sinclair E and Barbour JD: HIV-1 infection abrogates
CD8+ T cell mitogen-activated protein kinase signaling
responses. J Virol. 85:12343–12350. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
17
|
Rubinstein MP, Lind NA, Purton JF,
Filippou P, Best JA, McGhee PA, Surh CD and Goldrath AW: IL-7 and
IL-15 differentially regulate CD8+ T-cell subsets during
contraction of the immune response. Blood. 112:3704–3712. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Virgin HW, Wherry EJ and Ahmed R:
Redefining chronic viral infection. Cell. 138:30–50. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Burns GS and Thompson AJ: Viral hepatitis
B: Clinical and epidemiological characteristics. Cold Spring Harb
Perspect Med. 4:a0249352014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xie Q, Shen HC, Jia NN, Wang H, Lin LY, An
BY, Gui HL, Guo SM, Cai W, Yu H, et al: Patients with chronic
hepatitis B infection display deficiency of plasmacytoid dendritic
cells with reduced expression of TLR9. Microbes Infect. 11:515–523.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Woltman AM, Op den Brouw ML, Biesta PJ,
Shi CC and Janssen HL: Hepatitis B virus lacks immune activating
capacity, but actively inhibits plasmacytoid dendritic cell
function. PLoS One. 6:e153242011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Blackburn SD, Shin H, Haining WN, Zou T,
Workman CJ, Polley A, Betts MR, Freeman GJ, Vignali DA and Wherry
EJ: Coregulation of CD8+ T cell exhaustion by multiple
inhibitory receptors during chronic viral infection. Nat Immunol.
10:29–37. 2009. View
Article : Google Scholar
|
|
23
|
Klenerman P and Hill A: T cells and viral
persistence: Lessons from diverse infections. Nat Immunol.
6:873–879. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ou R, Zhang M, Huang L and Moskophidis D:
Control of virus-specific CD8+ T-cell exhaustion and
immune-mediated pathology by E3 ubiquitin ligase Cbl-b during
chronic viral infection. J Virol. 82:3353–3368. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Neefjes J, Jongsma ML, Paul P and Bakke O:
Towards a systems understanding of MHC class I and MHC class II
antigen presentation. Nat Rev Immunol. 11:823–836. 2011.PubMed/NCBI
|
|
26
|
Papadopoulos M and Momburg F: Multiple
residues in the transmembrane helix and connecting peptide of mouse
tapasin stabilize the transporter associated with the
antigen-processing TAP2 subunit. J Biol Chem. 282:9401–9410. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cabrera CM: The double role of the
endoplasmic reticulum chaperone tapasin in peptide optimization of
HLA class I molecules. Scand J Immunol. 65:487–493. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tey SK and Khanna R: Host immune system
strikes back: Autophagy-mediated antigen presentation bypasses
viral blockade of the classic MHC class I processing pathway.
Autophagy. 8:1839–1841. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen M and Bouvier M: Analysis of
interactions in a tapasin/class I complex provides a mechanism for
peptide selection. EMBO J. 26:1681–1690. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wearsch PA and Cresswell P: Selective
loading of high-affinity peptides onto major histocompatibility
complex class I molecules by the tapasin-ERp57 heterodimer. Nat
Immunol. 8:873–881. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Boulanger DS, Oliveira R, Ayers L, Prior
SH, James E, Williams AP and Elliott T: Absence of tapasin alters
immunodominance against a lymphocytic choriomeningitis virus
polytope. J Immunol. 184:73–83. 2010. View Article : Google Scholar
|
|
32
|
Sa Q, Woodward J and Suzuki Y: IL-2
produced by CD8+ immune T cells can augment their IFN-γ
production independently from their proliferation in the secondary
response to an intracellular pathogen. J Immunol. 190:2199–2207.
2013. View Article : Google Scholar : PubMed/NCBI
|
